Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery

PLoS Computational Biology

Volumn 9, Issue 10, 2013, Pages

  Spitzmüller, Andreas ^a   Mestres, Jordi ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASES;

CLINICAL USE; DRUG DISCOVERY; DRUG TARGETS; DRUG-TARGETING; ESSENTIAL PROTEINS; INFECTIOUS DISEASE; MECHANISM OF ACTION; P. FALCIPARUM; PARASITE-; TARGET SPACE;

PROTEINS;

AMINOMETHANOQUINOLINE DERIVATIVE; AMINOPYRIMIDINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE; BIGUANIDE; CARRIER PROTEIN; DOXYCYCLINE; FOLIC ACID ANTAGONIST; HEMOZOIN INHIBITOR DERIVATIVE; NAPHTHOQUINOLINE DERIVATIVE; PHOSPHOTRANSFERASE; PROGUANIL; PROTEINASE; PYRIMETHAMINE; RIBOSOME PROTEIN; SULFADOXINE; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG STRUCTURE; DRUG TARGETING; GENE IDENTIFICATION; GENETIC SCREENING; GENOME ANALYSIS; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE; PROTEIN TARGETING; PROTOZOAL GENETICS;

PLASMODIUM FALCIPARUM;

ANTIMALARIALS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATABASES, PROTEIN; DRUG DISCOVERY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84887308042     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003257     Document Type: Article

References (74)

1. World Health Organization (2012) World Malaria Report 2012. Geneva, Swizerland.
2. Calderón F, Wilson DM, Gamo F-J, (2013) Antimalarial drug discovery: recent progress and future directions. Prog Med Chem 52: 97-151 doi:10.1016/B978-0-444-62652-3.00003-X.
3. Petersen I, Eastman R, Lanzer M, (2011) Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett 585: 1551-1562 doi:10.1016/j.febslet.2011.04.042.
4. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, (2002) Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209-218.
5. Birkholtz L-M, Bastien O, Wells G, Grando D, Joubert F, et al. (2006) Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space? Malar J 5: 110 doi:10.1186/1475-2875-5-110.
6. Guiguemde WA, Shelat AA, Garcia-Bustos JF, Diagana TT, Gamo F-J, et al. (2012) Global phenotypic screening for antimalarials. Chem Biol 19: 116-129 doi:10.1016/j.chembiol.2012.01.004.
7. Guiguemde WA, Shelat A, Bouck D, Duffy S, Crowther GJ, et al. (2010) Chemical genetics of Plasmodium falciparum. Nature 465: 311-315 doi:10.1038/nature09099.
8. Gamo F-J, Sanz LM, Vidal J, De Cozar C, Alvarez E, et al. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465: 305-310 doi:10.1038/nature09107.
9. Gagaring K, Borboa R, Francek C, Chen Z, Buenviaje J, et al. Novartis-GNF Malaria Box, Genomics Institute of the Novartis Research Foundation (GNF), 10675 John Jay Hopkins Drive, San Diego CA 92121, USA and Novartis Institute for Tropical Disease, 10 Biopolis Road, Chromos # 05-01, 138 670 Singapore.
10. ChEMBL- Neglected Tropical Disease archive. Available: https://www.ebi.ac.uk/chemblntd.
11. Chatterjee AK, Yeung BKS, (2012) Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials. Curr Top Med Chem 12: 473-483.
12. Crowther GJ, Napuli AJ, Gilligan JH, Gagaring K, Borboa R, et al. (2011) Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Mol Biochem Parasitol 175: 21-29 doi:10.1016/j.molbiopara.2010.08.005.
13. Rottmann M, McNamara C, Yeung BKS, Lee MCS, Zou B, et al. (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329: 1175-1180 doi:10.1126/science.1193225.
14. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, et al. (2008) In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A 105: 9059-9064 doi:10.1073/pnas.0802982105.
15. Jensen K, Plichta D, Panagiotou G, Kouskoumvekaki I, (2012) Mapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leads. Mol Biosyst 8: 1678-1685 doi:10.1039/c2mb00008c.
16. PredictFX v12.3, Chemotargets SL, Barcelona (Catalonia).
17. Chen F, Mackey AJ, Stoeckert CJ, Roos DS, (2006) OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res 34: D363-8 doi:10.1093/nar/gkj123.
18. Solyakov L, Halbert J, Alam MM, Semblat J-P, Dorin-Semblat D, et al. (2011) Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun 2: 565 doi:10.1038/ncomms1558.
19. Sidhu ABS, Uhlemann A-C, Valderramos SG, Valderramos J-C, Krishna S, et al. (2006) Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 194: 528-535 doi:10.1086/507115.
20. Duraisingh MT, Cowman AF, (2005) Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181-190 doi:10.1016/j.actatropica.2005.04.008.
21. Zhang Y, Meshnick SR, (1991) Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs. Antimicrob Agents Chemother (Bethesda) 35: 267-271.
22. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB, (1999) Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33: 704-711.
23. Seymour KK, Lyons SD, Phillips L, Rieckmann KH, Christopherson RI, (1994) Cytotoxic Effects of Inhibitors of de Novo Pyrimidine Biosynthesis upon Plasmodium falciparum. Biochemistry 33: 5268-5274 doi:10.1021/bi00183a033.
24. Chopra I, Roberts M, (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65: 232-60 second page, table of contents. doi:10.1128/MMBR.65.2.232-260.2001.
25. Dahl EL, Shock JL, Shenai BR, Gut J, DeRisi JL, et al. (2006) Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (Bethesda) 50: 3124-3131 doi:10.1128/AAC.00394-06.
26. O'Neill PM, Barton VE, Ward SA, (2010) The molecular mechanism of action of artemisinin-the debate continues. Molecules 15: 1705-1721 doi:10.3390/molecules15031705.
27. Agüero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, et al. (2008) Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov 7: 900-907 doi:10.1038/nrd2684.
28. O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, et al. (2011) Open Babel: An open chemical toolbox. J Cheminform 3: 33 doi:10.1186/1758-2946-3-33.
29. Boran A, Iyengar R, (2010) Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel 13: 297-309.
30. Lu J-J, Pan W, Hu Y-J, Wang Y-T, (2012) Multi-Target Drugs: The Trend of Drug Research and Development. PLoS ONE 7: e40262 doi:10.1371/journal.pone.0040262.
31. Mestres J, Gregori-Puigjané E, Valverde S, Solé RV, (2009) The topology of drug-target interaction networks: implicit dependence on drug properties and target families. Mol Biosyst 5: 1051-1057 doi:10.1039/b905821b.
32. Jalencas X, Mestres J, (2013) On the origins of drug polypharmacology. Medchemcomm 4: 80-87 doi:10.1039/c2md20242e.
33. Jirage D, Keenan SM, Waters NC, (2010) Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets 10: 134-146.
34. Zhang VM, Chavchich M, Waters NC, (2012) Targeting protein kinases in the malaria parasite: update of an antimalarial drug target. Curr Top Med Chem 12: 456-472.
35. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132 doi:10.1038/nbt1358.
36. Liu J, Gluzman IY, Drew ME, Goldberg DE, (2005) The role of Plasmodium falciparum food vacuole plasmepsins. J Biol Chem 280: 1432-1437 doi:10.1074/jbc.M409740200.
37. Bebbington D, Binch H, Charrier J-D, Everitt S, Fraysse D, et al. (2009) The discovery of the potent aurora inhibitor MK-0457 (VX-680). Bioorg Med Chem Lett 19: 3586-3592 doi:10.1016/j.bmcl.2009.04.136.
38. Kumar R, Musiyenko A, Barik S, (2003) The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. Malar J 2: 30 doi:10.1186/1475-2875-2-30.
39. Giaever G, Chu AM, Ni L, Connelly C, Riles L, et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387-391 doi:10.1038/nature00935.
40. Tang WK, Xia D, (2012) Structural and functional deviations in disease-associated p97 mutants. J Struct Biol 179: 83-92 doi:10.1016/j.jsb.2012.04.024.
41. Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, et al. (2011) The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat Cell Biol 13: 1376-1382 doi:10.1038/ncb2367.
42. National Center for Biotechnology Information. PubChem BioAssay Database; AID = 488828, Source = Molecular Libraries Program, Specialized Chemistry Center, University of Kansas. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=488828. Accessed 30 April 2013.
43. Fennell BJ, Naughton JA, Dempsey E, Bell A, (2006) Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: tubulin as a specific antimalarial target. Mol Biochem Parasitol 145: 226-238 doi:10.1016/j.molbiopara.2005.08.020.
44. Li L, Wang HK, Kuo SC, Wu TS, Mauger A, et al. (1994) Antitumor agents. 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents. J Med Chem 37: 3400-3407.
45. Boumendjel A, Macalou S, Ahmed-Belkacem A, Blanc M, Di Pietro A, (2007) Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2. Bioorg Med Chem 15: 2892-2897 doi:10.1016/j.bmc.2007.02.017.
46. Eckers E, Cyrklaff M, Simpson L, Deponte M, (2012) Mitochondrial protein import pathways are functionally conserved among eukaryotes despite compositional diversity of the import machineries. Biol Chem 393: 513-524 doi:10.1515/hsz-2011-0255.
47. National Center for Biotechnology Information. PubChem BioAssay Database; AID = 493002, Source = Burnham Center for Chemical Genomics. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=493002. Accessed 29 April 2013.
48. Yi F, Regan L, (2008) A Novel Class of Small Molecule Inhibitors of Hsp90. ACS Chemical Biology 3: 645-654 doi:10.1021/cb800162x.
49. National Center for Biotechnology Information. PubChem BioAssay Database; AID = 1220, Source = Burnham Center for Chemical Genomics. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1220. Accessed 23 April 2013.
50. Payton MA, Rheinnecker M, Klig LS, DeTiani M, Bowden E, (1991) A novel Saccharomyces cerevisiae secretory mutant possesses a thermolabile phosphomannose isomerase. J Bacteriol 173: 2006-2010.
51. Smith DJ, Proudfoot AE, Detiani M, Wells TN, Payton MA, (1995) Cloning and heterologous expression of the Candida albicans gene PMI 1 encoding phosphomannose isomerase. Yeast 11: 301-310 doi:10.1002/yea.320110402.
52. Jeong J-J, Kumar A, Hanada T, Seo P-S, Li X, et al. (2006) Cloning and characterization of Plasmodium falciparum cysteine protease, falcipain-2B. Blood Cells Mol Dis 36: 429-435 doi:10.1016/j.bcmd.2006.02.003.
53. Sijwali PS, Shenai BR, Gut J, Singh A, Rosenthal PJ, (2001) Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J 360: 481-489.
54. National Center for Biotechnology Information. PubChem BioAssay Database; AID = 831, Source = PCMD. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=831. Accessed 30 April 2013.
55. National Center for Biotechnology Information. PubChem BioAssay Database; AID = 825, Source = PCMD. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=825. Accessed 30 April 2013.
56. Quevillon E, Spielmann T, Brahimi K, Chattopadhyay D, Yeramian E, et al. (2003) The Plasmodium falciparum family of Rab GTPases. Gene 306: 13-25.
57. Li X, Hilgers M, Cunningham M, Chen Z, Trzoss M, et al. (2011) Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines. Bioorg Med Chem Lett 21: 5171-5176 doi:10.1016/j.bmcl.2011.07.059.
58. Schormann N, Velu SE, Murugesan S, Senkovich O, Walker K, et al. (2010) Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase. Bioorg Med Chem 18: 4056-4066 doi:10.1016/j.bmc.2010.04.020.
59. Ommeh S, Nduati E, Mberu E, Kokwaro G, Marsh K, et al. (2004) In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum. Antimicrob Agents Chemother (Bethesda) 48: 3711-3714 doi:10.1128/AAC.48.10.3711-3714.2004.
60. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40: D1100-7 doi:10.1093/nar/gkr777.
61. Bolton EE, Wang Y, Thiessen PA, Bryant SH (2008) PubChem: Integrated Platform of Small Molecules and Biological Activities. In: Wheeler RA, Spellmeyer DC, editors. Annual Reports in Computational Chemistry Volume 4. Elsevier, Vol. 4. pp. 217-241. doi:10.1016/S1574-1400(08)00012-1.
62. Sharman JL, Mpamhanga CP, Spedding M, Germain P, Staels B, et al. (2011) IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data. Nucleic Acids Res 39: D534-8 doi:10.1093/nar/gkq1062.
63. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK, (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35: D198-201 doi:10.1093/nar/gkl999.
64. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for "omics" research on drugs. Nucleic Acids Res 39: D1035-41 doi:10.1093/nar/gkq1126.
65. Vidal D, Garcia-Serna R, Mestres J, (2011) Ligand-Based Approaches to In Silico Pharmacology. Methods Mol Biol 672: 489-502 doi:_10.1007/978-1-60761-839-3_19.
66. Gregori-Puigjané E, Mestres J, (2006) SHED: Shannon entropy descriptors from topological feature distributions. J Chem Inf Model 46: 1615-1622 doi:10.1021/ci0600509.
67. Vidal D, Mestres J, (2010) In Silico Receptorome Screening of Antipsychotic Drugs. Molecular Informatics 29: 543-551 doi:10.1002/minf.201000055.
68. Flachner B, Lörincz Z, Carotti A, Nicolotti O, Kuchipudi P, et al. (2012) A chemocentric approach to the identification of cancer targets. PLoS One 7: e35582 doi:10.1371/journal.pone.0035582.
69. Areias FM, Brea J, Gregori-Puigjané E, Zaki MEA, Carvalho MA, et al. (2010) In silico directed chemical probing of the adenosine receptor family. Bioorg Med Chem 18: 3043-3052 doi:10.1016/j.bmc.2010.03.048.
70. Mestres J, Seifert SA, Oprea TI, (2011) Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clin Pharmacol Ther 90: 662-665 doi:10.1038/clpt.2011.177.
71. Antolín AA, Jalencas X, Yélamos J, Mestres J, (2012) Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology. ACS Chem Biol 7: 1962-1967 doi:10.1021/cb300317y.
72. Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P, (2012) Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor. J Med Chem 55: 9838-9846 doi:10.1021/jm301055g.
73. R Core Team (2012) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
74. Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, et al. (2009) PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res 37: D539-43 doi:10.1093/nar/gkn814.